NORTHWEST BIOTHERAPEUTICS IN's ticker is NWBO and the CUSIP is 66737P600. A total of 6 filers reported holding NORTHWEST BIOTHERAPEUTICS IN in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $2,000 | -33.3% | 12,500 | 0.0% | 0.00% | – |
| Q4 2019 | $3,000 | 0.0% | 12,500 | 0.0% | 0.00% | – |
| Q3 2019 | $3,000 | 0.0% | 12,500 | 0.0% | 0.00% | – |
| Q2 2019 | $3,000 | 0.0% | 12,500 | 0.0% | 0.00% | – |
| Q1 2019 | $3,000 | 0.0% | 12,500 | 0.0% | 0.00% | – |
| Q4 2018 | $3,000 | +50.0% | 12,500 | 0.0% | 0.00% | – |
| Q3 2018 | $2,000 | -33.3% | 12,500 | 0.0% | 0.00% | – |
| Q2 2018 | $3,000 | 0.0% | 12,500 | 0.0% | 0.00% | – |
| Q1 2018 | $3,000 | 0.0% | 12,500 | 0.0% | 0.00% | – |
| Q4 2017 | $3,000 | +50.0% | 12,500 | 0.0% | 0.00% | – |
| Q3 2017 | $2,000 | 0.0% | 12,500 | 0.0% | 0.00% | – |
| Q2 2017 | $2,000 | -33.3% | 12,500 | 0.0% | 0.00% | – |
| Q1 2017 | $3,000 | -25.0% | 12,500 | 0.0% | 0.00% | – |
| Q4 2016 | $4,000 | -42.9% | 12,500 | 0.0% | 0.00% | – |
| Q3 2016 | $7,000 | 0.0% | 12,500 | 0.0% | 0.00% | – |
| Q2 2016 | $7,000 | -61.1% | 12,500 | 0.0% | 0.00% | – |
| Q1 2016 | $18,000 | -55.0% | 12,500 | 0.0% | 0.00% | -100.0% |
| Q4 2015 | $40,000 | – | 12,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Woodford Investment Management Ltd | 9,379,987 | $69,131,000 | 9.82% |
| Family Management Corp | 82,875 | $611,000 | 0.28% |
| Montecito Bank & Trust | 75,717 | $558,000 | 0.28% |
| Bedell Frazier Investment Counselling, LLC | 62,825 | $463,000 | 0.19% |
| Lyons Wealth Management, LLC. | 20,000 | $147,000 | 0.16% |
| Price Capital Management, Inc. | 28,864 | $213,000 | 0.13% |
| BOLTON LP | 50,000 | $369,000 | 0.10% |
| BOLTON LP | 50,000 | $369,000 | 0.10% |
| WEDBUSH SECURITIES INC | 76,500 | $564,000 | 0.10% |
| HYMAN CHARLES D | 43,375 | $320,000 | 0.05% |